Cognition Therapeutics, Inc. (CGTX)
NASDAQ: CGTX · Real-Time Price · USD
0.5822
-0.0184 (-3.06%)
At close: Nov 20, 2026, 4:00 PM EST
0.5800
-0.0022 (-0.38%)
After-hours: Nov 20, 2026, 7:51 PM EST
Cognition Therapeutics Market Cap
Cognition Therapeutics has a market cap or net worth of $55.37 million as of November 20, 2026. It is the 28,768th most valuable company in the world and the 4,422nd biggest in the United States. Its market cap has decreased by 54.88% in one year.
Market Cap
55.37M
Enterprise Value
25.10M
1-Year Change
-54.88%
Global Rank
Country Rank
#4,422 United States
Category
ChartMarket Cap Chart
Since the IPO on October 8, 2021, Cognition Therapeutics's market cap has decreased from $256.46M to $55.37M, a decrease of -78.41%. That is a compound annual growth rate of -25.87%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2026 | 55.37M | -53.54% |
| Dec 31, 2025 | 119.17M | 308.99% |
| Dec 31, 2024 | 29.14M | -50.97% |
| Dec 29, 2023 | 59.43M | -2.39% |
| Dec 30, 2022 | 60.88M | -56.29% |
| Dec 31, 2021 | 139.27M | -45.69% |
| Oct 8, 2021 (IPO) | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Atara Biotherapeutics | 65.25M |
| PDS Biotechnology | 64.78M |
| Champions Oncology | 63.91M |
| Neumora Therapeutics | 62.85M |
| Corbus Pharmaceuticals Holdings | 62.03M |
| Conexeu Sciences | 61.66M |
| Acrivon Therapeutics | 61.28M |
| Fortress Biotech | 60.70M |